What consumer-accessible tests can and cannot determine — that is the question, and I have not found it answered plainly anywhere I have looked.
Something about consumer-accessible tests does not reconcile and I would like a second pair of eyes before I decide which half is wrong.
Two sources, both reputable, giving figures that cannot both be right unless they are measuring different quantities. My suspicion is that they are, and I cannot see how.
Agreed, and I will stop repeating the version of this I had been repeating.
Confirming the opening post from a second method, which matters more than confirming it from a second person.
Molecular tests: DNA or RNA tests are not applicable to peptides, which do not contain nucleic acids. Peptide-specific tests rely on protein recognition, not nucleic-acid detection.
Scoping that to what I have actually seen rather than what I have read.
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
About the Home & field testing category
What consumer-accessible tests can and cannot tell you. Mostly a subcategory about limitations. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with…
|
4 | 51k | 11mo | |
|
Cost versus information: making the trade-off explicitly
Cost versus information: making the trade-off explicitly Writing it up because I had to work it out twice and would rather nobody else did. Asking about cost versus information directly, because I have read…
|
+2 | 6 | 12k | 11h |
|
A comparison of home results against a laboratory result on the same vial — does this still hold?
A comparison of home results against a laboratory result on the same vial — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Comparison of home…
|
+2 | 6 | 15k | 11h |
|
Lateral-flow and colorimetric approaches: the specificity problem
Lateral-flow and colorimetric approaches: the specificity problem — setting out what I have, and where I think it stops being reliable. Lateral-flow and colorimetric approaches, and specifically the version…
|
2 | 4k | 9mo | |
|
A comparison of home results against a laboratory result on the same vial
Posting this under the heading it deserves: A comparison of home results against a laboratory result on the same vial Everything below is what sits behind that. Comparison of home results against: setting out…
|
+61 | 65 | 35k | 8mo |
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
What a documentation review can and cannot tell you — a second dataset
The question in the title: What a documentation review can and cannot tell you — a second dataset I will give what I have already checked below so nobody repeats it. Posting a small dataset on documentation…
|
4 | 170 | 4mo | |
|
Reporting a good result: why nobody bothers and why they should — one year on
Posting this under the heading it deserves: Reporting a good result: why nobody bothers and why they should — one year on Everything below is what sits behind that. The question about Reporting a good result…
|
+19 | 27 | 4.7k | 18mo |
|
What a documentation review can and cannot tell you
What a documentation review can and cannot tell you — that is the question, and I have not found it answered plainly anywhere I have looked. Something about documentation review does not reconcile and I would…
|
+79 | 83 | 950 | 11mo |
|
[2026 update] A report I filed that turned out to be wrong, and the correction
On the subject in the title: A report I filed that turned out to be wrong, and the correction Working notes rather than a conclusion. Structured report rather than an opinion, following the format the…
|
+15 | 19 | 18k | 2d |
|
Reused chromatograms across lots: how to spot it — what changed since
Reused chromatograms across lots: how to spot it — what changed since — setting out what I have, and where I think it stops being reliable. What changes if the standard account of Reused chromatograms across…
|
+34 | 39 | 20k | 2mo |